Interview: Molecular neuro-oncology: a forward-looking perspective
Wolfgang Wick is the Chairman of the Department of Neuro-Oncology, Hertie Professor of Neuro-Oncology and Director at the National Tumor Center at the University of Heidelberg, Germany. He is conducting multicenter Phase III randomized trials for the Neuro-Oncology Working Group of the German Cancer...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 Dec 2013
|
| In: |
CNS Oncology
Year: 2013, Jahrgang: 2, Heft: 6, Pages: 491-493 |
| ISSN: | 2045-0915 |
| DOI: | 10.2217/cns.13.47 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2217/cns.13.47 Verlag, lizenzpflichtig, Volltext: https://www.futuremedicine.com/doi/10.2217/cns.13.47 
|
| Verfasserangaben: | Professor Wolfgang Wick speaks to Tess O’Neill, Head of Commissioning |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1776207181 | ||
| 003 | DE-627 | ||
| 005 | 20230428085606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211104s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/cns.13.47 |2 doi | |
| 035 | |a (DE-627)1776207181 | ||
| 035 | |a (DE-599)KXP1776207181 | ||
| 035 | |a (OCoLC)1341422411 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wick, Wolfgang |d 1970- |e InterviewteR |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 ive | |
| 245 | 1 | 0 | |a Interview: Molecular neuro-oncology |b a forward-looking perspective |c Professor Wolfgang Wick speaks to Tess O’Neill, Head of Commissioning |
| 264 | 1 | |c 16 Dec 2013 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.11.2021 | ||
| 520 | |a Wolfgang Wick is the Chairman of the Department of Neuro-Oncology, Hertie Professor of Neuro-Oncology and Director at the National Tumor Center at the University of Heidelberg, Germany. He is conducting multicenter Phase III randomized trials for the Neuro-Oncology Working Group of the German Cancer Society, the European Organisation for Research and Treatment of Cancer as well as a number of multicenter trials with the pharmaceutical industry. He is a steering committee member of the Neuro-Oncology Working Group and the European Association for Neuro-oncology as well as chairman of the European Organisation for Research and Treatment of Cancer Brain Tumor Group. His main scientific interests include migration and invasion of glioma cells, biomarkers and radiosensitization. | ||
| 700 | 1 | |a O'Neill, Tess |e InterviewerIn |0 (DE-588)1245067699 |0 (DE-627)1776209036 |4 ivr | |
| 773 | 0 | 8 | |i Enthalten in |t CNS Oncology |d London : Taylor & Francis, 2012 |g 2(2013), 6, Seite 491-493 |h Online-Ressource |w (DE-627)731333349 |w (DE-600)2692808-5 |w (DE-576)37613304X |x 2045-0915 |7 nnas |a Interview: Molecular neuro-oncology a forward-looking perspective |
| 773 | 1 | 8 | |g volume:2 |g year:2013 |g number:6 |g pages:491-493 |g extent:3 |a Interview: Molecular neuro-oncology a forward-looking perspective |
| 856 | 4 | 0 | |u https://doi.org/10.2217/cns.13.47 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.futuremedicine.com/doi/10.2217/cns.13.47 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211104 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1776207181 |e 3999141859 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Professor Wolfgang Wick speaks to Tess O’Neill, Head of Commissioning"]},"id":{"eki":["1776207181"],"doi":["10.2217/cns.13.47"]},"relHost":[{"pubHistory":["1.2012 -"],"origin":[{"publisher":"Taylor & Francis ; Future Medicine","dateIssuedKey":"2024","publisherPlace":"London ; London","dateIssuedDisp":"2024-"}],"part":{"issue":"6","text":"2(2013), 6, Seite 491-493","extent":"3","pages":"491-493","volume":"2","year":"2013"},"title":[{"title_sort":"CNS Oncology","title":"CNS Oncology"}],"id":{"zdb":["2692808-5"],"issn":["2045-0915"],"eki":["731333349"]},"note":["Gesehen am 18.06.24"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"731333349","physDesc":[{"extent":"Online-Ressource"}],"disp":"Interview: Molecular neuro-oncology a forward-looking perspectiveCNS Oncology"}],"person":[{"display":"Wick, Wolfgang","given":"Wolfgang","role":"ive","family":"Wick"},{"display":"O'Neill, Tess","given":"Tess","role":"ivr","family":"O'Neill"}],"origin":[{"dateIssuedDisp":"16 Dec 2013","dateIssuedKey":"2013"}],"note":["Gesehen am 04.11.2021"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Interview: Molecular neuro-oncology","title":"Interview: Molecular neuro-oncology","subtitle":"a forward-looking perspective"}],"physDesc":[{"extent":"3 S."}],"recId":"1776207181"} | ||
| SRT | |a INTERVIEWM1620 | ||